Kintai Therapeutics Announces Appointments of Industry Veterans to its Executive Leadership Team
July 16, 2020 08:00 ET
|
Kintai Therapeutics, Inc.
CAMBRIDGE, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a pioneer in unlocking the power of the human enteric signaling network and its signals throughout the body to combat disease...
Kintai Therapeutics Advances Anti-Obesity Agent KTX-0200 into IND-Enabling Studies Following Positive Preclinical Data Demonstrating Sustained Weight Loss and Improved Health Markers
January 22, 2020 08:00 ET
|
Kintai Therapeutics, Inc.
CAMBRIDGE, Mass., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced the advancement of KTX-0200, a novel oral anti-obesity agent, into...
Kintai Therapeutics Appoints Biotech Veteran John Mendlein, Ph.D., as Chairman of the Board of Directors
January 09, 2020 08:00 ET
|
Kintai Therapeutics, Inc.
CAMBRIDGE, Mass., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced the appointment of biotech industry veteran John Mendlein, Ph.D., to its Board...
Kintai Therapeutics Announces the Appointment of Dr. Francesca Barone as Head of Experimental Medicine
October 21, 2019 08:00 ET
|
Kintai Therapeutics, Inc.
CAMBRIDGE, Mass., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced that Francesca Barone, M.D., Ph.D., has joined Kintai as the head of...
Kintai Therapeutics Appoints Senior Executive Dr. Mark E. Nuttall as Chief Business Officer
September 11, 2019 07:00 ET
|
Kintai Therapeutics, Inc.
CAMBRIDGE, Mass. , Sept. 11, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a biotech company pioneering precision medicines by unlocking the power of the enteric signaling network, today announced...
Kintai Therapeutics Announces Collaborations with Leading Academic Centers to Identify Novel Targets for Cancer Therapeutics
August 27, 2019 08:00 ET
|
Kintai Therapeutics, Inc.
CAMBRIDGE, Mass., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced that it has established new collaborations with leading academic institutions...
Kintai Therapeutics Announces the Appointment of Mary Szela, Industry Veteran with Over 30 Years of Executive Experience, to its Board of Directors
July 23, 2019 08:00 ET
|
Kintai Therapeutics, Inc.
CAMBRIDGE, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced that Mary Szela, chief executive officer and president of TriSalus Life...
Kintai Therapeutics Announces Formation of World-Class Scientific Advisory Board
May 29, 2019 08:00 ET
|
Kintai Therapeutics, Inc.
CAMBRIDGE, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company developing precision therapeutics based on enteric signaling networks, today announced the...